Opportunity Information: Apply for CDC RFA GH15 1617
Apply for CDC RFA GH15 1617
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Reducing the burden of neglected parasitic infections (NPIs) in the United States through evidence based prevention and control activities" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.084 Prevention of Disease, Disability, and Death by Infectious Diseases.
- This funding opportunity was created on Feb 24, 2015 and posted on Jan 13, 2015.
- Applicants must submit their applications by Mar 20, 2015 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- The number of recipients for this funding is limited to 4 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
- The award ceiling for this FOA is 200,000. CDC will consider any application requesting an award higher than this amount as non responsive and it will receive no further review. Applicants can focus on a single objective, single disease of the 5 included here, or apply to work on any combination of the 5 diseases in this FOA.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This CDC funding opportunity (RFA GH15-1617) is a discretionary cooperative agreement designed to reduce the burden of neglected parasitic infections (NPIs) in the United States by supporting evidence-based prevention and control work. The overall aim is practical public health impact: projects are expected to lead to better prevention behaviors, faster and more accurate recognition of illness, stronger guidance on best practices, and improved capacity for education and identification of these infections. The CDC frames NPIs as a priority because they affect large numbers of people, can cause serious disease, and are often preventable and treatable when awareness, guidance, and access to appropriate practices are in place.
The opportunity focuses on five specific parasitic diseases identified by CDC as neglected parasitic infections: Chagas disease, neurocysticercosis, toxocariasis, toxoplasmosis, and trichomoniasis. Applicants are not required to address all five; they can target a single disease, a single objective, or any combination across these infections. The common thread is that proposed activities should be grounded in evidence and oriented toward prevention and control outcomes rather than purely descriptive work. The CDC emphasizes deliverables such as new or improved strategies, educational tools and materials, and guidelines that can be used broadly to strengthen public health practice.
A major feature of the announcement is its focus on education, training, and guidance development as mechanisms for population-level benefit. The tools and materials developed under this funding are intended to improve preventive health knowledge and practices related to NPIs, increase recognition of signs and symptoms among relevant audiences, and expand the availability of recommended approaches and clear, usable guidance. The FOA also highlights capacity building: strengthening the ability of systems and stakeholders to provide public education on NPIs and to identify these infections more effectively. In practical terms, competitive projects would likely be those that translate existing evidence into actionable products and approaches that can be adopted by public health programs, clinicians, educators, and communities at risk.
The CDC is explicit about the characteristics it wants in funded strategies: they should be capable of high-impact public health outcomes, reach a high proportion of people at risk, and offer strong potential for meaningful improvements in population health. That framing signals a preference for interventions and products that are scalable and implementable, rather than niche efforts with limited reach. It also implies applicants should think carefully about dissemination, uptake, and real-world use of any educational materials or guidelines they propose, since the ultimate goal is measurable reduction in disease burden through better prevention and control practices.
From an administrative standpoint, the program is funded through CFDA 93.084 (Prevention of Disease, Disability, and Death by Infectious Diseases) and uses a cooperative agreement mechanism, which typically means CDC expects substantial involvement or collaboration during the project period compared with a standard grant. The estimated total funding listed is $1,000,000, with an expectation of four awards. The award ceiling is $200,000, and applications requesting more than that are deemed nonresponsive and are not reviewed further. There is no cost sharing or matching requirement. Eligibility is described as unrestricted (open broadly to entity types), subject to any clarifications that may have appeared in the full announcement text.
Key dates in the posted record show the FOA was posted January 13, 2015, with an original closing date of March 13, 2015, and a current closing date of March 20, 2015. Applications were required to be submitted electronically by 11:59 p.m. Eastern Time on the due date, and the opportunity was archived April 19, 2015. For applicants who needed assistance accessing the full announcement, the contact listed was Liz Wilkins (MSc, MBA) at BVL5@CDC.GOV and pgotim@cdc.gov, with a phone number of 770-488-2700.
FAQs: CDC RFA GH15-1617 - Neglected Parasitic Infections (NPIs)
What is this funding opportunity?
This is a CDC discretionary cooperative agreement (RFA GH15-1617) intended to reduce the burden of neglected parasitic infections (NPIs) in the United States by supporting evidence-based prevention and control work with practical public health impact.
What is the overall goal of the program?
The goal is to achieve real-world prevention and control outcomes, including better prevention behaviors, faster and more accurate recognition of illness, stronger guidance on best practices, and improved capacity for education and identification of NPIs.
Why does CDC consider neglected parasitic infections a priority?
CDC frames NPIs as a priority because they affect large numbers of people, can cause serious disease, and are often preventable and treatable when awareness, guidance, and appropriate practices are in place.
Which diseases are included as the targeted neglected parasitic infections?
The opportunity focuses on five CDC-identified NPIs: Chagas disease, neurocysticercosis, toxocariasis, toxoplasmosis, and trichomoniasis.
Do applicants have to address all five infections?
No. Applicants are not required to address all five. They may target a single disease, a single objective, or any combination across these infections.
What kinds of activities does CDC want to fund?
CDC emphasizes evidence-based activities oriented toward prevention and control outcomes. The announcement highlights education, training, guidance development, and capacity building as key mechanisms for achieving population-level benefit.
Are projects focused only on describing the problem competitive?
The common thread described is that activities should be grounded in evidence and oriented toward prevention and control outcomes rather than purely descriptive work.
What types of deliverables are expected?
Examples of deliverables emphasized include new or improved strategies, educational tools and materials, and guidelines that can be used broadly to strengthen public health practice.
Who are the intended users of the tools, materials, or guidance produced?
The materials and approaches are described as intended for broad use in strengthening prevention and control, including adoption by public health programs, clinicians, educators, and communities at risk.
What does the FOA say about education and training?
Education and training are central features. The tools and materials are intended to improve preventive health knowledge and practices related to NPIs, increase recognition of signs and symptoms among relevant audiences, and expand the availability of recommended approaches and clear, usable guidance.
What does capacity building mean in this announcement?
Capacity building is described as strengthening the ability of systems and stakeholders to provide public education on NPIs and to identify these infections more effectively.
What characteristics does CDC want in the funded strategies?
CDC states that funded strategies should be capable of high-impact public health outcomes, reach a high proportion of people at risk, and have strong potential for meaningful improvements in population health.
Does the announcement suggest preferences about scale or reach?
Yes. The framing signals a preference for interventions and products that are scalable and implementable, rather than niche efforts with limited reach, and it implies attention to dissemination, uptake, and real-world use.
What funding mechanism is being used?
The opportunity uses a cooperative agreement mechanism, which typically means CDC expects substantial involvement or collaboration during the project period compared with a standard grant.
What is the CFDA number for this program?
The program is funded through CFDA 93.084 (Prevention of Disease, Disability, and Death by Infectious Diseases).
How much total funding is available, and how many awards are expected?
The estimated total funding listed is $1,000,000, with an expectation of four awards.
What is the maximum award amount per application?
The award ceiling is $200,000.
What happens if an application requests more than the award ceiling?
Applications requesting more than $200,000 are deemed nonresponsive and are not reviewed further.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is described as unrestricted (open broadly to entity types), subject to any clarifications that may have appeared in the full announcement text.
When was the FOA posted, and what were the key due dates?
The posted record shows the FOA was posted January 13, 2015, with an original closing date of March 13, 2015, and a current closing date of March 20, 2015.
What time were applications due on the closing date?
Applications were required to be submitted electronically by 11:59 p.m. Eastern Time on the due date.
Is this opportunity still open?
No. The opportunity was archived April 19, 2015.
Who can be contacted for help accessing the full announcement?
The listed contact for assistance accessing the full announcement was Liz Wilkins (MSc, MBA) at BVL5@CDC.GOV and pgotim@cdc.gov, phone 770-488-2700.
What outcomes is CDC trying to achieve through funded projects?
The described outcomes include improved prevention behaviors, improved recognition of signs and symptoms, stronger best-practice guidance, broader availability of recommended approaches, and improved education and identification capacity, all aimed at reducing NPI burden.
Browse more opportunities from the same category: Health
Next opportunity: Shared Instrumentation Grant (SIG) Program (S10)
Previous opportunity: NIH Big Data to Knowledge (BD2K) Enhancing Diversity in Biomedical Data Science (R25)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1617
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1617) also looked into and applied for these:
| Funding Opportunity |
|---|
| Shared Instrumentation Grant (SIG) Program (S10) Apply for PAR 15 088 Funding Number: PAR 15 088 Agency: National Institutes of Health Category: Health Funding Amount: $600,000 |
| FY15 Research, Monitoring and Outcomes Definitions for Vaccine Safety Apply for NV VSR 15 001 Funding Number: NV VSR 15 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $250,000 |
| US Platform to Measure Influenza Vaccine Effectiveness against Laboratory confirmed Influenza associated Apply for RFA IP 15 002 Funding Number: RFA IP 15 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Increasing Participation of People with Disabilities in USAID Activities and Strengthen the Capacities of Disabled Peoples Organizations (DPOs). Apply for RFA 114 15 000006 Funding Number: RFA 114 15 000006 Agency: Georgia USAID Tbilisi Category: Health Funding Amount: $600,000 |
| Maternal Newborn and Child Health Activity Apply for RFA 611 15 000001 Funding Number: RFA 611 15 000001 Agency: Zambia USAID Lusaka Category: Health Funding Amount: $7,500,000 |
| Program Expansion Supplement for GH11 1109, Strengthening Local Capacity to Provide Sustainable HIV Related Care and Treatment Services in South Africa under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH11 11090501SUPP15 Funding Number: CDC RFA GH11 11090501SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $24,000,000 |
| Analyze and Evaluate Potential Risk Factors for Amyotrophic Lateral Sclerosis (ALS) Apply for RFA TS 15 001 Funding Number: RFA TS 15 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $400,000 |
| R40 MCH Autism Secondary Data Analysis Studies Program Apply for HRSA 15 083 Funding Number: HRSA 15 083 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Quality Improvement Capacity for Impact Project Apply for HRSA 15 021 Funding Number: HRSA 15 021 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| NIGMS Program of Administrative Supplements for Equipment (Admin Supp) Apply for PA 15 089 Funding Number: PA 15 089 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Hospital Preparedness Program (HPP) and Public Health Emergency Preparedness (PHEP) Cooperative Agreements / PHEP Supplemental for Ebola Preparedness and Response Activities Apply for CDC RFA TP12 12010302SUPP15 Funding Number: CDC RFA TP12 12010302SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $9,232,987 |
| NIAMS Rheumatic Diseases Research Resource based Centers (P30) Apply for RFA AR 16 002 Funding Number: RFA AR 16 002 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Stillbirth Risk Factor Pilot Project Centers for Birth Defects Research and Prevention (CBDRPs) Apply for RFA DD 15 004 Funding Number: RFA DD 15 004 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Drug Free Communities Support Program Apply for SP 15 001 Funding Number: SP 15 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $125,000 |
| Cooperative Agreement for Networking, Certifying, and Training Suicide Prevention Hotlines and Disaster Distress Helpline Apply for SM 15 007 Funding Number: SM 15 007 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $6,211,000 |
| Intramural NIGMS Postdoctoral Research Associate (PRAT) Program (FI2) Apply for PAR 15 094 Funding Number: PAR 15 094 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| National Fetal, Infant and Child Death Review Center Program Apply for HRSA 15 069 Funding Number: HRSA 15 069 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| FY15 Announcement of Anticipated Availability of Funds for One Family Planning Clinical Training Cooperative Agreement Apply for PA FPT 15 001 Funding Number: PA FPT 15 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $750,000 |
| Population based Diabetes in Youth Registry Apply for RFA DP 15 002 Funding Number: RFA DP 15 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $380,000 |
| Promoting Adolescent Health through School Based HIV/STD Prevention and School Based Surveillance Apply for CDC RFA PS13 130803CONT15 Funding Number: CDC RFA PS13 130803CONT15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1617", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.